364 related articles for article (PubMed ID: 7139616)
1. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
Goldenberg GJ; Froese EK
Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
[TBL] [Abstract][Full Text] [Related]
2. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
3. Receptor status and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol.
Brandes LJ; Hermonat MW
Cancer Res; 1983 Jun; 43(6):2831-5. PubMed ID: 6850594
[TBL] [Abstract][Full Text] [Related]
4. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
5. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
Osborne CK; Boldt DH; Estrada P
Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
Reddel RR; Murphy LC; Hall RE; Sutherland RL
Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
[TBL] [Abstract][Full Text] [Related]
7. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
8. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
Mueck AO; Seeger H; Wallwiener D
Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
Reddel RR; Murphy LC; Sutherland RL
Cancer Res; 1984 Jun; 44(6):2398-405. PubMed ID: 6722780
[TBL] [Abstract][Full Text] [Related]
10. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
[TBL] [Abstract][Full Text] [Related]
11. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
Gao HD; Sun JZ; Bi DS; Ma R
Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
[TBL] [Abstract][Full Text] [Related]
12. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
14. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
Briand P; Lykkesfeldt AE
Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
[TBL] [Abstract][Full Text] [Related]
15. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Res; 1976 Dec; 36(12):4595-601. PubMed ID: 1000504
[TBL] [Abstract][Full Text] [Related]
16. Influence of tamoxifen and estradiol on the growth of human breast cancer cells in vitro.
Arafah BM; Griffin P; Gordon NH; Pearson OH
Cancer Res; 1986 Jul; 46(7):3268-72. PubMed ID: 3708561
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells.
Gierthy JF; Lincoln DW; Roth KE; Bowser SS; Bennett JA; Bradley L; Dickerman HW
J Cell Biochem; 1991 Feb; 45(2):177-87. PubMed ID: 2055945
[TBL] [Abstract][Full Text] [Related]
18. Effect of cytotoxic drugs on estrogen receptor expression and response to tamoxifen in MCF-7 cells.
Clarke R; Morwood J; van den Berg HW; Nelson J; Murphy RF
Cancer Res; 1986 Dec; 46(12 Pt 1):6116-9. PubMed ID: 3779632
[TBL] [Abstract][Full Text] [Related]
19. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
20. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]